BACKGROUND: Currently, multiplex ligation-dependent probe amplification (MLPA) is the most commonly used technique for the detection of large genomic rearrangements (LGRs) in the BRCA1/2 genes. However, a very fast assay, the BRCA1/2 multiplex amplicon quantification (MAQ), has been recently developed by Multiplicom. METHODS: As no data regarding the application of MAQ method to BRCA1/2 genes are available in literature, here we compared for the first time the performance of the MAQ assay with MLPA by using several positive BRCA1/2 LGRs DNA samples (previously tested by MLPA). RESULTS: MAQ method was able to detect all BRCA1/2 LGRs and no false-positive or -negative results were obtained in independent repetitive experiments. CONCLUSIONS...
Next-generation sequencing (NGS) has enabled new approaches for detection of mutations in the BRCA1 ...
International audienceThe recent deployment of next-generation sequencing approaches in routine labo...
International audienceRecent studies have revealed a significant proportion of BRCA1 exon deletions ...
BACKGROUND: Currently, multiplex ligation-dependent probe amplification (MLPA) is the most commonly ...
Introduction: Currently, genetic testing of BRCA1/2 genes includes screening for single-nucleotide v...
PARP inhibitors are used for treatment of tumors lacking function of the double-strand DNA break rep...
Aim of the study: Evaluation of copy number variation (CNV) in BRCA1/2 genes, due to large genomic r...
Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the det...
BACKGROUND: BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers t...
Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires...
Twenty-three percent of first diagnosed breast cancer patients resulted to be candidate for BRCA gen...
Detection of mutations by DNA sequencing can be facilitated by scanning methods to identify amplicon...
The recent advances in the next-generation sequencing (NGS) technology have enabled fast, accurate, ...
Next-generation sequencing (NGS) has enabled new approaches for detection of mutations in the BRCA1 ...
International audienceThe recent deployment of next-generation sequencing approaches in routine labo...
International audienceRecent studies have revealed a significant proportion of BRCA1 exon deletions ...
BACKGROUND: Currently, multiplex ligation-dependent probe amplification (MLPA) is the most commonly ...
Introduction: Currently, genetic testing of BRCA1/2 genes includes screening for single-nucleotide v...
PARP inhibitors are used for treatment of tumors lacking function of the double-strand DNA break rep...
Aim of the study: Evaluation of copy number variation (CNV) in BRCA1/2 genes, due to large genomic r...
Gerhardus A, Schleberger H, Schlegelberger B, Gadzicki D. Diagnostic accuracy of methods for the det...
BACKGROUND: BRCA1 and BRCA2 are the two major genes responsible for the breast and ovarian cancers t...
Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires...
Twenty-three percent of first diagnosed breast cancer patients resulted to be candidate for BRCA gen...
Detection of mutations by DNA sequencing can be facilitated by scanning methods to identify amplicon...
The recent advances in the next-generation sequencing (NGS) technology have enabled fast, accurate, ...
Next-generation sequencing (NGS) has enabled new approaches for detection of mutations in the BRCA1 ...
International audienceThe recent deployment of next-generation sequencing approaches in routine labo...
International audienceRecent studies have revealed a significant proportion of BRCA1 exon deletions ...